middle.news
Resonance Health funds three growth bets after a profitable FY26
12:45pm on Thursday 19th of November, 2026 AEDT
•
Healthcare
Read Story
Resonance Health funds three growth bets after a profitable FY26
12:45pm on Thursday 19th of November, 2026 AEDT
Key Points
FY26 revenue rose 42% to $15.8 million
Net profit reached $1.5 million after a $1.7 million loss
Oversubscribed $6 million placement funded obesity endpoints, TrialsWest expansion and fibrosis-device development
FY27 guidance is $17 million to $22 million revenue and $2.6 million to $3.6 million normalised EBITDA
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE